Vaccines produced by Pfizer/Bio NTech and Moderna could be given approval for market by mid December , European Commission President Ursula von der Leyen said Thursday . 
She added that this is the " very , very first step to be able to go on to the market " with both of these vaccines . 
The Commission president said that all vaccines are properly assessed by the EMA and authorized in cooperation with other authorities . 
They worked closely with the FDA on authorization of the Bio NTech and Moderna vaccines . 
The European Commission now has contracts with Pfizer/Bio NTech , Curevac , Astra Zeneca , Johnson & Johnson and Sanofi and continue negotiations with Moderna . 
They are also still in talks with Novavax . 
